Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-22-027883

Chief Financial Officer sold 5,700 shares at $10.90 ($62,130)

From the SEC's structured data for this filing

Trades in this filing

Doyle Anthony · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-12-15 Sale : show line 1 in the form −5,700 $10.90 $62,130 163,966 D
Open-market sales · 5,700 sh · avg $10.90 · $62,130
Loading xslF345X03/form4.xml…